Lv6
1658 积分 2023-10-16 加入
Distinctive Molecular Risk Factors Between MDS and MDS / AML Defined by ICC
1个月前
已完结
Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation
2个月前
已完结
Advances in biology, diagnosis and treatment of DLBCL
3个月前
已完结
Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma
3个月前
已完结
Recent advances in genomics and therapeutics in mantle cell lymphoma
5个月前
已完结
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
5个月前
已完结
NSD2 serves as a potential prognostic biomarker in mantle cell lymphoma
6个月前
已完结
Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines
8个月前
已完结
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
8个月前
已完结
Concurrent TP53 and CDKN2A Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy
8个月前
已完结
皖公网安备34019202002308
